Literature DB >> 10653883

Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature.

J S Jacobson1, S B Workman, F Kronenberg.   

Abstract

PURPOSE: This article reviews English-language articles published in the biomedical literature from 1980 to 1997 that reported results of clinical research on complementary and alternative medical treatments (CAM) of interest to patients with breast cancer.
METHODS: We searched 12 electronic databases and the bibliographies of the retrieved papers, review articles, and books on CAM and breast cancer. The retrieved articles were grouped by end point: breast cancer (eg, tumor size, survival), disease-related symptoms, side effects of treatment, and immune function. Within each end point, we organized the articles by modality and assessed study design, findings, and qualitative aspects.
RESULTS: Of the more than 1,000 citations retrieved, 51 fit our criteria for review. Of the articles reviewed, 17 were randomized clinical trials; three of these were trials of cancer-directed interventions, two of which involved the same treatment (melatonin). Seven articles described observational studies, and the remainder were reports of phase I or II trials. Relatively few CAM modalities reportedly used by many breast cancer patients were mentioned in articles retrieved by this process. Most articles had shortcomings.
CONCLUSION: Although many studies had encouraging results, none showed definitively that a CAM treatment altered disease progression in patients with breast cancer. Several modalities seemed to improve other outcomes (eg, acupuncture for nausea, pressure treatments for lymphedema). If CAM studies are well-founded, well-designed, and meticulously conducted, and their hypotheses, methods, and results are reported clearly and candidly, research in this controversial area should acquire credibility both in the scientific community and among advocates of unconventional medicine.

Entities:  

Mesh:

Year:  2000        PMID: 10653883     DOI: 10.1200/JCO.2000.18.3.668

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  20 in total

1.  Biologically based complementary and alternative medicine use among breast cancer survivors: relationship to dietary fat consumption and exercise.

Authors:  Mary C Politi; Carolyn Rabin; Bernardine Pinto
Journal:  Support Care Cancer       Date:  2006-04-19       Impact factor: 3.603

2.  Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.

Authors:  Eunyoung Kang; Eun Joo Yang; Sun-Mi Kim; Il Yong Chung; Sang Ah Han; Do-Hoon Ku; Soek-Jin Nam; Jung-Hyun Yang; Sung-Won Kim
Journal:  Support Care Cancer       Date:  2011-01-28       Impact factor: 3.603

Review 3.  Polypharmacy in the Geriatric Oncology Population.

Authors:  Lauren R Hersh; Kathryn Beldowski; Emily R Hajjar
Journal:  Curr Oncol Rep       Date:  2017-09-23       Impact factor: 5.075

4.  Coordination and management of multisite complementary and alternative medicine (CAM) therapies: experience from a multisite reflexology intervention trial.

Authors:  Mohammad H Rahbar; Gwen Wyatt; Alla Sikorskii; David Victorson; Manouchehr Ardjomand-Hessabi
Journal:  Contemp Clin Trials       Date:  2011-06-02       Impact factor: 2.226

Review 5.  Adverse events associated with complementary and alternative medicine use in ovarian cancer patients.

Authors:  Erin S Sweet; Leanna J Standish; Barbara A Goff; M Robyn Andersen
Journal:  Integr Cancer Ther       Date:  2013-04-26       Impact factor: 3.279

Review 6.  Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review.

Authors:  Esther L Davis; Byeongsang Oh; Phyllis N Butow; Barbara A Mullan; Stephen Clarke
Journal:  Oncologist       Date:  2012-08-29

7.  Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors.

Authors:  Rayna Kim Matsuno; Ian S Pagano; Gertraud Maskarinec; Brian F Issell; Carolyn C Gotay
Journal:  J Womens Health (Larchmt)       Date:  2012-10-17       Impact factor: 2.681

8.  The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California.

Authors:  Marilyn L Kwan; Christine B Ambrosone; Marion M Lee; Janice Barlow; Sarah E Krathwohl; Isaac Joshua Ergas; Christine H Ashley; Julie R Bittner; Jeanne Darbinian; Keren Stronach; Bette J Caan; Warren Davis; Susan E Kutner; Charles P Quesenberry; Carol P Somkin; Barbara Sternfeld; John K Wiencke; Shichun Zheng; Lawrence H Kushi
Journal:  Cancer Causes Control       Date:  2008-05-14       Impact factor: 2.506

Review 9.  The treatment of lymphedema related to breast cancer: a systematic review and evidence summary.

Authors:  Lyn Kligman; Rebecca K S Wong; Mary Johnston; Nancy S Laetsch
Journal:  Support Care Cancer       Date:  2004-04-17       Impact factor: 3.603

10.  Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer.

Authors:  John A Chabot; Wei-Yann Tsai; Robert L Fine; Chunxia Chen; Carolyn K Kumah; Karen A Antman; Victor R Grann
Journal:  J Clin Oncol       Date:  2009-08-17       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.